Presence of the human leukocyte antigen class II gene DRB1*1101 Predicts interferon γ levels and disease recurrence in melanoma patients

Annals of Surgical Oncology

Volumn 9, Issue 6, 2002, Pages 587-593

  Lee, Jeffrey E ^a   Abdalla, Joseph ^a   Porter, Geoffrey A ^a   Bradford, Loretta ^a   Grimm, Elizabeth A ^a   Reveille, John D ^a   Mansfield, Paul F ^a   Gershenwald, Jeffrey E ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Disease recurrence; HLA class II; Interferon ; Melanoma

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 2;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; GENE IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREDICTION; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TEXAS;

EID: 0036064935     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.6.587     Document Type: Article

References (31)

1. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
2. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene
3. + melanoma
4. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
5. HLA and adult T cell leukaemia. HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I
6. Association of gastric adenocarcinoma with the HLA class II gene DQB1*0301
7. HLA-DQB1*0301 association with increased melanoma risk
8. Association of HLA-DQB1*0301 with malignant melanoma
9. Malignant melanoma: Relationship of the human leukocyte antigen class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer stage I or II
10. Interleukin 10 (IL-10): An immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
11. Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients
12. Elevated plasma levels of interleukin-10 in patients with metastatic malignant melanoma
13. Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes
14. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes
15. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
16. IMGT/HLA database - A sequence database for the human major histocompatibility complex
17. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines
18. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes
19. Expression of cytokine mRNA in human melanoma tissues
20. Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: A Southwest Oncology Group study
21. Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: Results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987
22. Phenotypic profiles of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γ
23. Differential susceptibility to recombinant interferon-γ-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma
24. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells
25. HLA-DR antigen expression in primary melanomas of the skin
26. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression
27. The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells
28. MHC antigens in human melanomas
29. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumor necrosis factor-α genes: A technical report
30. Induced heteroduplex genotyping of TNF-alpha, IL-1 beta, II-6 and IL-10 polymorphisms associated with transcriptional regulation
31. Association of polymorphism in the interferon gamma gene with IDDM